New Zealand - English - Medsafe (Medicines Safety Authority)

upjohn new zealand ulc - ziprasidone hydrochloride monohydrate 45.3mg equivalent to 40 mg ziprasidone; ziprasidone hydrochloride monohydrate 67.95mg equivalent to 60 mg ziprasidone; ziprasidone hydrochloride monohydrate 90.6mg equivalent to 80 mg ziprasidone - capsule - active: ziprasidone hydrochloride monohydrate 45.3mg equivalent to 40 mg ziprasidone excipient: gelatin lactose monohydrate magnesium stearate pregelatinised maize starch active: ziprasidone hydrochloride monohydrate 67.95mg equivalent to 60 mg ziprasidone excipient: gelatin lactose monohydrate magnesium stearate pregelatinised maize starch active: ziprasidone hydrochloride monohydrate 90.6mg equivalent to 80 mg ziprasidone excipient: gelatin lactose monohydrate magnesium stearate pregelatinised maize starch - ziprasidone is also indicated as a monotherapy for the short term treatment of acute manic or mixed episodes associated with bipolar 1 disorder.

New Zealand - English - Medsafe (Medicines Safety Authority)

upjohn new zealand ulc - ziprasidone hydrochloride monohydrate 45.3mg equivalent to 40 mg ziprasidone - capsule - 40 mg - active: ziprasidone hydrochloride monohydrate 45.3mg equivalent to 40 mg ziprasidone excipient: gelatin lactose monohydrate magnesium stearate pregelatinised maize starch tekprint black sw-9008 - ziprasidone is indicated for the treatment of acute schizophrenia, and maintenance or continuation therapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - ziprasidone hydrochloride monohydrate 113.25mg equivalent to 100 mg ziprasidone - capsule - 100 mg - active: ziprasidone hydrochloride monohydrate 113.25mg equivalent to 100 mg ziprasidone excipient: lactose monohydrate magnesium stearate pregelatinised maize starch - ziprasidone is indicated for the treatment of acute schizophrenia, and maintenance or continuation therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - ziprasidone hydrochloride monohydrate, quantity: 45.3 mg (equivalent: ziprasidone, qty 40 mg) - capsule, hard - excipient ingredients: magnesium stearate; indigo carmine; titanium dioxide; lactose monohydrate; pregelatinised maize starch; gelatin; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - zeldox (ziprasidone) is indicated for: (i) the treatment of schizophrenia, related psychoses, prevention of relapse and for maintenance of clinical improvement during continuation therapy; and (ii) as monotherapy for the short term treatment of acute manic or mixed episodes associated with bipolar i disorder.

New Zealand - English - Medsafe (Medicines Safety Authority)

upjohn new zealand ulc - ziprasidone hydrochloride monohydrate 22.652mg equivalent to 20 mg ziprasidone - capsule - 20 mg - active: ziprasidone hydrochloride monohydrate 22.652mg equivalent to 20 mg ziprasidone excipient: gelatin lactose monohydrate magnesium stearate pregelatinised maize starch tekprint black sw-9008 - ziprasidone is indicated for the treatment of acute schizophrenia, and maintenance or continuation therapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

upjohn new zealand ulc - ziprasidone hydrochloride monohydrate 67.95mg equivalent to 60 mg ziprasidone - capsule - 60 mg - active: ziprasidone hydrochloride monohydrate 67.95mg equivalent to 60 mg ziprasidone excipient: gelatin lactose monohydrate magnesium stearate pregelatinised maize starch tekprint black sw-9008 - ziprasidone is indicated for the treatment of acute schizophrenia, and maintenance or continuation therapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

upjohn new zealand ulc - ziprasidone hydrochloride monohydrate 90.6mg equivalent to 80 mg ziprasidone - capsule - 80 mg - active: ziprasidone hydrochloride monohydrate 90.6mg equivalent to 80 mg ziprasidone excipient: gelatin lactose monohydrate magnesium stearate pregelatinised maize starch tekprint black sw-9008 - ziprasidone is indicated for the treatment of acute schizophrenia, and maintenance or continuation therapy.

Canada - English - Health Canada

genmed a division of pfizer canada ulc - ziprasidone (ziprasidone hydrochloride monohydrate) - capsule - 40mg - ziprasidone (ziprasidone hydrochloride monohydrate) 40mg - atypical antipsychotics

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - ziprasidone hydrochloride monohydrate, quantity: 90.6 mg - capsule, hard - excipient ingredients: titanium dioxide; pregelatinised maize starch; lactose monohydrate; gelatin; indigo carmine; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - zeldox (ziprasidone) is indicated for the treatment of schizophrenia, related psychoses, prevention of relapse and for maintenance of clinical improvement during continuation therapy; as monotherapy for the short term treatment of acute manic or mixed episodes associated with bipolar i disorder.

Canada - English - Health Canada

genmed a division of pfizer canada ulc - ziprasidone (ziprasidone hydrochloride monohydrate) - capsule - 20mg - ziprasidone (ziprasidone hydrochloride monohydrate) 20mg - atypical antipsychotics